Henryk Szymański

1.0k total citations
23 papers, 430 citations indexed

About

Henryk Szymański is a scholar working on Epidemiology, Infectious Diseases and Food Science. According to data from OpenAlex, Henryk Szymański has authored 23 papers receiving a total of 430 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 9 papers in Infectious Diseases and 8 papers in Food Science. Recurrent topics in Henryk Szymański's work include Probiotics and Fermented Foods (8 papers), Viral gastroenteritis research and epidemiology (7 papers) and Respiratory viral infections research (7 papers). Henryk Szymański is often cited by papers focused on Probiotics and Fermented Foods (8 papers), Viral gastroenteritis research and epidemiology (7 papers) and Respiratory viral infections research (7 papers). Henryk Szymański collaborates with scholars based in Poland, United States and France. Henryk Szymański's co-authors include Hania Szajewska, Magdalena Strus, Piotr B. Heczko, Agnieszka Chmielarczyk, Kinga Kowalska‐Duplaga, Bernadeta Patro-Gołąb, Dorota Gieruszczak‐Białek, Hanna Czajka, Teresa Jackowska and Jerzy Brzostek and has published in prestigious journals such as New England Journal of Medicine, The Journal of Pediatrics and Vaccine.

In The Last Decade

Henryk Szymański

22 papers receiving 415 citations

Peers

Countries citing papers authored by Henryk Szymański

Since Specialization

Citations

This map shows the geographic impact of Henryk Szymański's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henryk Szymański with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henryk Szymański more than expected).

Fields of papers citing papers by Henryk Szymański

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henryk Szymański. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henryk Szymański. The network helps show where Henryk Szymański may publish in the future.

Co-authorship network of co-authors of Henryk Szymański

This figure shows the co-authorship network connecting the top 25 collaborators of Henryk Szymański. A scholar is included among the top collaborators of Henryk Szymański based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henryk Szymański. Henryk Szymański is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) Administered with Routine Pediatric Vaccines: A European Randomized Controlled Trial 2025 ·Infectious Diseases and Therapy ·Federico Martinón‐Torres, Miia Virta, (unknown), Ignacio Salamanca de la Cueva, Henryk Szymański, Samantha Bosis, (unknown), Sven‐Arne Silfverdal, Betzana Zambrano, Mandeep Singh Dhingra, (unknown), (unknown), (unknown), Gloria Vásquez, (unknown), (unknown)	1
2	Practice in bronchiolitis management in Polish hospitals—a multicenter retrospective cohort study 2024 ·European Journal of Pediatrics ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Daniel Struck, (unknown), (unknown), Henryk Szymański	1
3	Nebulised 3% hypertonic saline versus 0.9% saline for treating patients hospitalised with acute bronchiolitis: protocol for a randomised, double-blind, multicentre trial 2023 ·BMJ Open ·(unknown), (unknown), Henryk Szymański	0
4	A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled Phase III Clinical Trial Evaluating the Impact of BCG Re-Vaccination on the Incidence and Severity of SARS-CoV-2 Infections among Symptomatic Healthcare Professionals during the COVID-19 Pandemic in Poland—Evaluation of Antibody Concentrations 2022 ·Vaccines ·(unknown), (unknown), Anna Nowakowska, Łukasz J. Krzych, Henryk Szymański, (unknown), Teresa Jackowska, Dorota Darmochwał-Kolarz, Artur Mazur, Hanna Czajka	6
5	A Multi-Center, Randomised, Double-Blind, Placebo-Controlled Phase III Clinical Trial Evaluating the Impact of BCG Re-Vaccination on the Incidence and Severity of SARS-CoV-2 Infections among Symptomatic Healthcare Professionals during the COVID-19 Pandemic in Poland—First Results 2022 ·Vaccines ·Hanna Czajka, (unknown), Łukasz J. Krzych, (unknown), (unknown), Anna Nowakowska, Teresa Jackowska, Dorota Darmochwał-Kolarz, Henryk Szymański, (unknown), Artur Mazur	29
6	Immunogenicity and safety of a quadrivalent high-dose inactivated influenza vaccine compared with a standard-dose quadrivalent influenza vaccine in healthy people aged 60 years or older: a randomized Phase III trial 2021 ·Human Vaccines & Immunotherapeutics ·Stéphanie Pépin, Jean‐François Nicolas, Henryk Szymański, Isabel Leroux‐Roels, Thomas Schaum, Marc J. M. Bonten, Giancarlo Icardi, Anju Shrestha, (unknown), (unknown)	25
7	Post hoc analysis of fecal samples from responders and non-responders to Lactobacillus reuteri DSM 17938 intervention 2020 ·Acta Biochimica Polonica ·Henryk Szymański, Piotr Młynarz, (unknown), Agnieszka Korzeniowska‐Kowal, Bogumiła Szponar, (unknown), Hania Szajewska	6
8	Assessment of an optimized manufacturing process for inactivated quadrivalent influenza vaccine: a phase III, randomized, double-blind, safety and immunogenicity study in children and adults 2018 ·BMC Infectious Diseases ·Carine Claeys, Mamadou Dramé, José García-Sicilia, Khalequ Zaman, Alfonso Carmona, (unknown), (unknown), Federico Martinón‐Torres, Franck Thollot, (unknown), Tino F. Schwarz, Ulrich Behre, José Merino, Iwona Sadowska-Krawczenko, Henryk Szymański, (unknown), Elisabeth Neumeier, Ping Li, Varsha Jain, Bruce L. Innis	6
9	A randomized study of fever prophylaxis and the immunogenicity of routine pediatric vaccinations 2017 ·Vaccine ·Jacek Wysocki, Jerzy Brzostek, Ewa Majda-Stanisławska, Henryk Szymański, Leszek Szenborn, Hanna Czajka, (unknown), (unknown), Teresa Jackowska, (unknown), (unknown), Ryszard Konior, Peter C. Giardina, Vani Sundaraiyer, Scott D. Patterson, William C. Gruber, Daniel A. Scott, Alejandra Gurtman	27
10	Efficacy of Lactobacillus Reuteri DSM 17938 for the Treatment of Acute Gastroenteritis in Children: Protocol of a Randomized Controlled Trial 2017 ·JMIR Research Protocols ·Henryk Szymański, Hania Szajewska	3
11	Effects of infant formula supplemented with prebiotics compared with synbiotics on growth up to the age of 12 mo: a randomized controlled trial 2017 ·Pediatric Research ·Hania Szajewska, Marek Ruszczyński, Henryk Szymański, Iwona Sadowska-Krawczenko, Anna Piwowarczyk, (unknown), (unknown), Christina West, Olle Hernell	16
12	Safety, immunogenicity, and lot-to-lot consistency of a split-virion quadrivalent influenza vaccine in younger and older adults: A phase III randomized, double-blind clinical trial 2017 ·Human Vaccines & Immunotherapeutics ·Sanie Sesay, Jerzy Brzostek, Ingo Meyer, Yves Donazzolo, Geert Leroux‐Roels, Roman Rouzier, B Astruc, Henryk Szymański, Nicole Toursarkissian, Corinne Vandermeulen, (unknown), Pierre Van Damme, Camille Salamand, Stéphanie Pépin	17
13	Effectiveness of Lactobacillus reuteri DSM 17938 for the Prevention of Nosocomial Diarrhea in Children 2015 ·The Pediatric Infectious Disease Journal ·(unknown), Dorota Gieruszczak‐Białek, Henryk Szymański, Hania Szajewska	22
14	Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine administered to older infants and children naïve to pneumococcal vaccination 2015 ·Vaccine ·Jacek Wysocki, Jerzy Brzostek, Henryk Szymański, (unknown), Ewa Toporowska‐Kowalska, Krystyna Wąsowska‐Królikowska, (unknown), Peter C. Giardina, William C. Gruber, Emilio A. Emini, Daniel A. Scott	15
15	Efficacy and safety of a new apple‐flavoured oral rehydration solution in children with acute gastroenteritis: a double‐blind randomized controlled trial 2012 ·Acta Paediatrica ·Małgorzata Pieścik‐Lech, Henryk Szymański, Hania Szajewska	3
16	Oral Zinc for the Treatment of Acute Gastroenteritis in Polish Children: A Randomized, Double-Blind, Placebo-Controlled Trial 2010 ·The Journal of Pediatrics ·Bernadeta Patro-Gołąb, Henryk Szymański, Hania Szajewska	27
17	<i>Bifidobacterium longum</i> PL03, <i>Lactobacillus rhamnosus</i> KL53A, and <i>Lactobacillus plantarum</i> PL02 in the Prevention of Antibiotic-Associated Diarrhea in Children: A Randomized Controlled Pilot Trial 2008 ·Digestion ·Henryk Szymański, (unknown), Kinga Kowalska‐Duplaga, Hania Szajewska	40
18	Colonisation of the gastrointestinal tract by probiotic L. rhamnosus strains in acute diarrhoea in children 2006 ·Digestive and Liver Disease ·Henryk Szymański, Agnieszka Chmielarczyk, Magdalena Strus, (unknown), (unknown), Piotr Kochan, Piotr B. Heczko	15
19	Treatment of acute infectious diarrhoea in infants and children with a mixture of three Lactobacillus rhamnosus strains – a randomized, double‐blind, placebo‐controlled trial 2005 ·Alimentary Pharmacology & Therapeutics ·Henryk Szymański, (unknown), (unknown), Agnieszka Chmielarczyk, Magdalena Strus, Piotr B. Heczko	98
20	[Medical applications of probiotics]. 2005 ·PubMed ·Piotr B. Heczko, Magdalena Strus, (unknown), Henryk Szymański	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact